Logo-header-sito-copia copia

MAIN TOPICS

Genetics & Epidemiology

  • Genetics and genomics in Celiac Disease

  • Triggering the disease: the exposome in Celiac Disease

  • Is it possible to predict Celiac Disease?

  • Celiac Disease around the world

  • Celiac disease and autoimmunity

Triggers and drivers

  • Wheat proteins, diet, innate immunity and inflammation

  • Gluten as a driver

  • Bacteria as triggers of Celiac Disease

  • The role of intestinal microbiota

  • Viral infections and Celiac Disease

Diagnosis

  • Biomarkers

  • Quantitative pathology in coeliac disease: trials and clinical use

  • Not all celiacs are equal: toward a personalized approach

Clinical Challenges

  • Mucosal healing: relevant, frequent, assured

  • Potential Celiac Disease

  • Refractory Celiac Disease

  • Gluten sensitivity in NCGS: guilt or innocence

New treatments and prevention

  • Animal models to test new treatments

  • Which primary endpoint for new therapies

  • Enzyme therapy

  • Il-15/IL-21 inhibition

  • TG2 Inhibition

  • Immune tolerance

  • Is prevention only a matter for kids?

  • Possible strategies for prevention: handling gluten, protection from infection, manipulation microbiota, modulation T cell mediated immune response

Clinical Forum

Diagnosis

  • Toward one protocol for children and adults

  • Biomarkers: the future of diagnosis

  • Present and future of histology in Celiac Disease

  • Advanced endoscopy techniques and Celiac Disease

  • Gluten challenge and novel immune diagnostics

Clinical presentations and associate conditions

  • Is clinical presentation changing in children?

  • Potential Celiac Disease

  • Type 1 diabetes and Celiac Disease

  • Association between IBD and Celiac Disease

  • IBS and Celiac Disease

Clinical challenges

  • How to make diagnosis on gluten-free diet?

  • Seronegative villous atrophy

  • Covid-19 and Celiac Disease

  • Mortality in Celiac Disease

  • Which protocol for follow-up

  • Transition

  • Quality of life in Celiac Disease

Gluten-free diet and Managment

  • Assessment of compliance

  • Contamination/food labeling

  • Role of dietician

  • Role of patient’s groups

  • Rol of Celiac Centers

  • Health economics and Celiac Disease

Other gluten-related disorders

  • Gluten sensitivity today

  • FODMAP as drivers for NCGS/NCWS

Diagnosis

  • Toward one protocol for children and adults

  • Biomarkers: the future of diagnosis

  • Present and future of histology in Celiac Disease

  • Advanced endoscopy techniques and Celiac Disease

  • Gluten challenge and novel immune diagnostics

Clinical presentations and associate conditions

  • Is clinical presentation changing in children?

  • Potential Celiac Disease

  • Type 1 diabetes and Celiac Disease

  • Association between IBD and Celiac Disease

  • IBS and Celiac Disease

Clinical challenges

  • How to make diagnosis on gluten-free diet?

  • Seronegative villous atrophy

  • Covid-19 and Celiac Disease

  • Mortality in Celiac Disease

  • Which protocol for follow-up

  • Transition

  • Quality of life in Celiac Disease

Gluten-free diet and Managment

  • Assessment of compliance

  • Contamination/food labeling

  • Role of dietician

  • Role of patient’s groups

  • Rol of Celiac Centers

  • Health economics and Celiac Disease

Other gluten-related disorders

  • Gluten sensitivity today

  • FODMAP as drivers for NCGS/NCWS

Scientific Forum

Genetics & Epidemiology

  • Genetics and genomics in Celiac Disease

  • Triggering the disease: the exposome in Celiac Disease

  • Is it possible to predict Celiac Disease?

  • Celiac Disease around the world

  • Celiac disease and autoimmunity

Triggers and drivers

  • Wheat proteins, diet, innate immunity and inflammation

  • Gluten as a driver

  • Bacteria as triggers of Celiac Disease

  • The role of intestinal microbiota

  • Viral infections and Celiac Disease

Diagnosis

  • Biomarkers

  • Quantitative pathology in coeliac disease: trials and clinical use

  • Not all celiacs are equal: toward a personalized approach

Clinical Challenges

  • Mucosal healing: relevant, frequent, assured

  • Potential Celiac Disease

  • Refractory Celiac Disease

  • Gluten sensitivity in NCGS: guilt or innocence

New treatments and prevention

  • Animal models to test new treatments

  • Which primary endpoint for new therapies

  • Enzyme therapy

  • Il-15/IL-21 inhibition

  • TG2 Inhibition

  • Immune tolerance

  • Is prevention only a matter for kids?

  • Possible strategies for prevention: handling gluten, protection from infection, manipulation microbiota, modulation T cell mediated immune response